European journal of human genetics : EJHG · 2024
Novel variants in the SOX11 gene: clinical description of seven new patients.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Schincariol-Manhe Beatriz, Campagnolo Érica, Spineli-Silva Samira, de Leeuw Nicole, Correia-Costa Gabriela Roldão, Pessoa André, de Souza Carolina Fischinger Moura, Stevens Cathy, Javaher Poupak, Scallet Helena Fabbri, Mohr Julia, Biskup Saskia, Herkert Johanna C, Pfundt Rolph, Mehta Lakshmi, Rekab Aisha, Elloumi Houda Zghal, Sanyoura May, Maciel-Guerra Andréa Trevas, Gil-da-Silva-Lopes Vera Lúcia, Dos Santos Ana Mondadori, Vieira Társis Paiva
Аннотация
Pathogenic SOX11 variants have been associated with intellectual developmental disorder with microcephaly, and with or without ocular malformations or hypogonadotropic hypogonadism (HH) (IDDMOH, OMIM # 615866). In this article, we report seven new patients with de novo SOX11 variants. Five of the variants are missense, one nonsense, and one whole-gene deletion, most of them are novel variants. The main clinical features included neurodevelopmental delay (7/7) and intellectual disability (5/7), autism/attention deficit hyperactivity disorder (5/7), microcephaly (4/7), short stature (4/7), hypotonia (4/7), and clinodactyly of the 5th fingers (5/7). HH was confirmed in two female patients with primary amenorrhea, nonvisualized/prepubertal size of the uterus, and nonvisualized ovaries. Two of the male patients presented with micropenis, two had cryptorchidism, and one had decreased testicular size, which are suggestive findings of HH. This article contributes to the clinical characterization of patients with SOX11 variants and supports the role of this gene in HH.